Strategies for the identification of inhibitors of West Nile virus and other flaviviruses

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The recent outbreaks of West Nile virus (WNV) and other emerging and re-emerging flaviviruses, have made prevention and treatment of flavivirus infections a global public health priority. No inhibitor is currently available for use as an antiflavivirus. therapy. In this communication, I review (i) stages of flavivirus replication representing potential targets for antiviral drug discovery; (ii) strategies for identification of flavivirus inhibitors; and (iii) existing antiviral inhibitors reported to have anti-WNV or other antiflavivirus activities. Flaviviruses share conserved nucleotide elements and amino acid sequences, and have similar genome organization and replication strategies. As such, it is hoped that broad spectrum flavivirus inhibitors could be identified through screening of compound libraries.

Original languageEnglish (US)
Pages (from-to)1567-1573
Number of pages7
JournalCurrent Opinion in Investigational Drugs
Volume3
Issue number11
StatePublished - Nov 1 2002
Externally publishedYes

Fingerprint

Flavivirus
West Nile virus
Antiviral Agents
Flavivirus Infections
Health Priorities
Drug Discovery
Libraries
Disease Outbreaks
Amino Acid Sequence
Nucleotides
Public Health
Genome

Keywords

  • Flavivirus
  • RNase L
  • West Nile virus

ASJC Scopus subject areas

  • Pharmacology

Cite this

Strategies for the identification of inhibitors of West Nile virus and other flaviviruses. / Shi, Pei-Yong.

In: Current Opinion in Investigational Drugs, Vol. 3, No. 11, 01.11.2002, p. 1567-1573.

Research output: Contribution to journalArticle

@article{ea95f8e0a6f24154ae0a6690d1c5b1f2,
title = "Strategies for the identification of inhibitors of West Nile virus and other flaviviruses",
abstract = "The recent outbreaks of West Nile virus (WNV) and other emerging and re-emerging flaviviruses, have made prevention and treatment of flavivirus infections a global public health priority. No inhibitor is currently available for use as an antiflavivirus. therapy. In this communication, I review (i) stages of flavivirus replication representing potential targets for antiviral drug discovery; (ii) strategies for identification of flavivirus inhibitors; and (iii) existing antiviral inhibitors reported to have anti-WNV or other antiflavivirus activities. Flaviviruses share conserved nucleotide elements and amino acid sequences, and have similar genome organization and replication strategies. As such, it is hoped that broad spectrum flavivirus inhibitors could be identified through screening of compound libraries.",
keywords = "Flavivirus, RNase L, West Nile virus",
author = "Pei-Yong Shi",
year = "2002",
month = "11",
day = "1",
language = "English (US)",
volume = "3",
pages = "1567--1573",
journal = "Expert Opinion on Investigational Drugs",
issn = "1354-3784",
publisher = "Taylor and Francis Ltd.",
number = "11",

}

TY - JOUR

T1 - Strategies for the identification of inhibitors of West Nile virus and other flaviviruses

AU - Shi, Pei-Yong

PY - 2002/11/1

Y1 - 2002/11/1

N2 - The recent outbreaks of West Nile virus (WNV) and other emerging and re-emerging flaviviruses, have made prevention and treatment of flavivirus infections a global public health priority. No inhibitor is currently available for use as an antiflavivirus. therapy. In this communication, I review (i) stages of flavivirus replication representing potential targets for antiviral drug discovery; (ii) strategies for identification of flavivirus inhibitors; and (iii) existing antiviral inhibitors reported to have anti-WNV or other antiflavivirus activities. Flaviviruses share conserved nucleotide elements and amino acid sequences, and have similar genome organization and replication strategies. As such, it is hoped that broad spectrum flavivirus inhibitors could be identified through screening of compound libraries.

AB - The recent outbreaks of West Nile virus (WNV) and other emerging and re-emerging flaviviruses, have made prevention and treatment of flavivirus infections a global public health priority. No inhibitor is currently available for use as an antiflavivirus. therapy. In this communication, I review (i) stages of flavivirus replication representing potential targets for antiviral drug discovery; (ii) strategies for identification of flavivirus inhibitors; and (iii) existing antiviral inhibitors reported to have anti-WNV or other antiflavivirus activities. Flaviviruses share conserved nucleotide elements and amino acid sequences, and have similar genome organization and replication strategies. As such, it is hoped that broad spectrum flavivirus inhibitors could be identified through screening of compound libraries.

KW - Flavivirus

KW - RNase L

KW - West Nile virus

UR - http://www.scopus.com/inward/record.url?scp=0036881355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036881355&partnerID=8YFLogxK

M3 - Article

C2 - 12476954

AN - SCOPUS:0036881355

VL - 3

SP - 1567

EP - 1573

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

SN - 1354-3784

IS - 11

ER -